Illumina Announces First Illumina Genomics Forum with a Conversation with Former US President Barack Obama

President Obama will participate in a fireside chat on the evening of Wednesday, September 28. Twelve years after the Affordable Care Act was passed, Obama will discuss the continued need for equity, accessibility, and smarter health care to improve the human condition.

“We are thrilled to welcome President Obama. Few presidents have fought for equitable, accessible, and affordable health care with as much perseverance and passion as barack obama,” said Catherine Reeves, chief marketing officer of Illumina. “The era of genomics has arrived and I can’t think of a more fitting and timely keynote speaker for the inaugural Illumina Genomics Forum, as we continue to advocate for expanded access to the lifesaving potential of genomics.”

At Illumina, innovation is in our DNA. Our vision is to provide access to genomic medicine to every patient in need and the Illumina Genomics Forum will bring together global leaders from all genomics and healthcare ecosystems to discuss the collaborations and actions needed to make genomic health a more inclusive and accessible standard of care. It will also showcase advances in genomics technologies that are positively impacting the world by improving predictive care, diagnostics and the development of new therapies. The main themes and discussion topics of the Illumina Genomics Forum include:

  • How genomic technology drives more informed, proactive and personalized patient diagnosis and treatment in clinics every day.
  • Advances full genome sequencing made against cancer, genetic and infectious diseases.
  • The Role of Genomics in Supporting Healthcare quadruple lens to improve population health, reduce costs, improve patient experience and improve provider satisfaction.

Additional speakers and program details for the event will be released in the coming weeks. We invite you to learn more and register at https://www.illuminagenomicsforum.com.

About Illumina

lllumina improves human health by unleashing the power of the genome. Our focus on innovation has enabled us to become a global leader in DNA sequencing and chip-based technologies, serving customers in the research, clinical and application markets. Our products are used for applications in life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us at TwitterFacebook, LinkedIn, Instagram and YouTube.

Investors:
Salli Schwartz
858.291.6421
[email protected]

Media:
Adi Raval
US: 202.629.8172
[email protected]

SOURCEIllumina, Inc.

About Nicole Harmon

Check Also

Logiq (OTCMKTS:WEYL) vs. Etsy (NASDAQ:ETSY) Financial Analysis

Logiq (OTCMKTS:WEYL – Get Rating) and Etsy (NASDAQ:ETSY – Get Rating) are both retail/wholesale companies, …